21.02.2007 13:00:00
|
Quovadx to Present Strategies for Standards-Based Interoperability in a Service Oriented Architecture
Quovadx, Inc. (Nasdaq: QVDX), a global software and vertical solutions
company, today announced its participation in the upcoming Healthcare
Information Management Systems Society Annual Conference and Exhibition
(HIMSS 2007). As part of the company’s
activities at the conference, Rey Currie, vice president of product
management, Quovadx, will present strategies for leveraging legacy
applications to support standards-based interoperability in a web
services environment. Quovadx will also host a series of events during
the course of the conference. HIMSS 2007 will be held at the Ernest N.
Morial Convention Center in New Orleans, Louisiana from February
25-March 1, 2007.
Rey Currie’s presentation, entitled "Leveraging
Legacy Applications to Enable IHE Document Sharing within a Service
Oriented Architecture,” will highlight best
practices in using the Integrating the Healthcare Enterprise (IHE)
framework for healthcare interoperability to facilitate document sharing
across the enterprise. Further, Mr. Currie will cover the promise of
utilizing service oriented architecture (SOA) in the healthcare
enterprise and solutions integrating legacy applications and IHE within
a SOA environment.
"Healthcare organizations are facing many
hurdles to embracing SOA such as a high number of legacy applications
that are not SOA ready,” said Rey Currie, vice
president of product management, Quovadx. "By
using IHE’s framework for healthcare
interoperability, and non-invasive solutions to connect legacy
applications and implement IHE profiles within a SOA environment, such
as Cloverleaf® Integration Suite, healthcare
organizations can increase their ability to exchange documents within
and outside their four walls to increase efficiency and improve patient
care.”
In the course of the presentation, attention will be placed on the value
of IHE’s framework for healthcare
interoperability in improving the quality and efficiency of care and
providing a framework for universal data access between healthcare
organizations and functions. Further, SOA and web services will be
examined in context of facilitating the creation of new user
functionality by mixing and matching established applications,
components from newer applications and internally developed code.
In addition to Mr. Currie’s presentation,
Quovadx will be hosting several other programs during HIMSS 2007:
Healthcare Executive Dinner & Networking Event – Quovadx, in collaboration with Intel, will host an interactive
dinner for healthcare executives featuring formal remarks from Newt
Gingrich, former Speaker of the U.S. House of Representatives and
Founder of the Center for Health Transformation. Mr. Gingrich will
share his insight and experience with health providers across the
country that are embracing interoperability solutions, and as a
result, are improving patient safety and quality of care, and reducing
costs.
Breakfast Forums The Value of Patient Medication History at the Point-of-Care - Quovadx
will team with RxHub to host a breakfast forum on the impact of
patient medication history at the point-of-care. This breakfast
session, lead by Ken Majkowski, PharmD, vice president, clinical
affairs, RxHub, and Jerry Rankin, director of health information
network initiatives for Quovadx, will discuss the Joint Commission’s
patient safety requirements for medication reconciliation, discuss
pilot projects and case studies and introduce an automated
approach to accessing accurate and detailed medication history at
point-of-care.
Transforming Healthcare for Payers & Providers -
Infosys and Quovadx will discuss how organizations can focus on
helping organizations transform disparate data networks into a
congruent source of information enabling patient-centric data
transparency. During the discussion, the two organizations will
share their experience as partners and individually in helping
healthcare organizations to standardize how health information is
managed.
Clinical Interoperability Partner Panel –
This 30-minute panel discussion will feature speakers from RxHub,
Infosys and 3M Health Information Systems, and will provide insight as
to how HIT’s organization can use Cloverleaf®
health interoperability software and services to extend the
interoperability reach of their products to their customers and
partners, connect to additional data sources, such as pharmacy and lab
data and act as a data source and intermediary for other data
consuming applications, governing bodies and business partner systems,
including RHIO participation.
Terminology Standardization for Clinical Interoperability -
Jerry Rankin, director of health information network initiatives for
Quovadx, will join Kasey Poon, M.D. and Medical Informaticist for the
Healthcare Data Dictionary Group of 3M Health Information Systems in a
discussion of terminology and coding in the industry today. The
session will cover who would use standard terminologies including why
and how, current deployment and capabilities.
Clinical Engineering and IT Leadership Forum - Leslie Kelly
Hall, director of technology consulting at HDR, and Tony Caruso of
Duke University Health System will address the importance of strategic
planning of new medical technologies and the importance of
facilitating interoperability solutions as part of the IHE initiative
to the safety and efficacy of the healthcare environment.
Mr. Currie’s presentation will be held in the
Interoperability Showcase at HIMSS on Tuesday, February 27th, 11:45 am.
A full schedule of Quovadx events and additional details can be found
online at http://www.isd-quovadx.com/isdevents/2007-himss/index.cfm.
To RSVP for any of the events above or included online, please contact
Cari Meredith at
720-554-1252.
Quovadx will also be exhibiting at HIMSS 2007 at booth number 7237.
About Cloverleaf® Integration Suite
The Cloverleaf Integration Suite, a system integration solution for
healthcare providers and payers, has installations in over 2,000 sites
worldwide and in 40 percent of all large IDNs (Integrated Delivery
Networks) in the U.S. Cloverleaf technology connects disparate IT
systems and applications across an enterprise or beyond, normalizes the
data for presentation and transforms the data into value-rich
information. Based on a flexible and reliable messaging platform, the
Cloverleaf solution enables real-time sharing of clinical,
administrative and financial data throughout an organization, maximizing
the value of existing technology systems and decreasing the cost of
integrating the healthcare enterprise.
About Quovadx, Inc.
Quovadx (Nasdaq: QVDX) offers software and services for system
development, extension, integration and analysis to enterprise customers
worldwide. Quovadx has three divisions, including the Integration
Solutions division (ISD), which offers private and public healthcare
organizations software infrastructure to facilitate system
interoperability and leverage existing technology; the CareScience
division, which provides care management and analytical solutions to
hospitals and health systems and pioneered regional healthcare
information organization (RHIO) technology; and the Rogue Wave Software
division, which provides software and services for enterprise-class
application development and high-performance SOA. Quovadx serves
companies in the healthcare, financial services, telecommunication and
public sectors. For more information, please visit http://www.quovadx.com.
QUOVADX and Cloverleaf are registered trademarks of Quovadx, Inc. in
the US and other countries. All other company and product names
mentioned may be trademarks of the companies with which they are
associated.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Quovadx Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |